Lindsay B Harrison

Summary

Affiliation: University of Texas Southwestern Medical Center
Country: USA

Publications

  1. doi request reprint Type 1 diabetes treatment beyond insulin: role of GLP-1 analogs
    Lindsay B Harrison
    Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX 75390, USA
    J Investig Med 61:40-4. 2013
  2. pmc Intensive therapy in newly diagnosed type 2 diabetes: results of a 6-year randomized trial
    Lindsay B Harrison
    From the Divisions of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Biostatistics, Department of Clinical Sciences, Mineral Metabolism, Department of Internal Medicine, and Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, TX
    J Investig Med 62:676-86. 2014
  3. doi request reprint Mechanisms of Action of Liraglutide in Patients With Type 2 Diabetes Treated With High-Dose Insulin
    Anna Vanderheiden
    Department of Internal Medicine A V, L B H, J T W, B A H, L M P, I L, Division of Endocrinology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 Texas Diabetes and Endocrinology L B H, Austin, Texas 78749 Departments of Clinical Sciences B A H, X L, I L and Radiology Q Y, K H, T Y, A W J, D F P, I P, R E L, University of Texas Southwestern Medical Center, Dallas, Texas 75390 Philips Medical Systems I D, Cleveland, Ohio 44143 and Advanced Imaging Research Center T Y, I P, R E L, University of Texas Southwestern Medical Center, Dallas, Texas 75390
    J Clin Endocrinol Metab 101:1798-806. 2016
  4. pmc β-cell function preservation after 3.5 years of intensive diabetes therapy
    Lindsay B Harrison
    Department of Internal Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Texas Southwestern Medical Center, Dallas, TX, USA
    Diabetes Care 35:1406-12. 2012

Collaborators

  • Ildiko Lingvay
  • Anna Vanderheiden
  • Robert E Lenkinski
  • Ivan Pedrosa
  • Keith Hulsey
  • Qing Yuan
  • Adam W Jaster
  • Beverley Adams-Huet
  • Ivan Dimitrov
  • Takeshi Yokoo
  • Xilong Li
  • Daniella F Pinho
  • Jeremy T Warshauer
  • Laurentiu M Pop

Detail Information

Publications4

  1. doi request reprint Type 1 diabetes treatment beyond insulin: role of GLP-1 analogs
    Lindsay B Harrison
    Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX 75390, USA
    J Investig Med 61:40-4. 2013
    ..To observe the efficacy and safety of glucagonlike peptide-1 (GLP-1) analogs in type 1 diabetes in a real-life medical practice setting...
  2. pmc Intensive therapy in newly diagnosed type 2 diabetes: results of a 6-year randomized trial
    Lindsay B Harrison
    From the Divisions of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Biostatistics, Department of Clinical Sciences, Mineral Metabolism, Department of Internal Medicine, and Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, TX
    J Investig Med 62:676-86. 2014
    ..This study aimed to assess the efficacy of early intensive diabetes therapy with either insulin plus metformin (INS) or triple oral therapy (TOT) with metformin, glyburide, and pioglitazone on glycemic control and A-cell function...
  3. doi request reprint Mechanisms of Action of Liraglutide in Patients With Type 2 Diabetes Treated With High-Dose Insulin
    Anna Vanderheiden
    Department of Internal Medicine A V, L B H, J T W, B A H, L M P, I L, Division of Endocrinology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 Texas Diabetes and Endocrinology L B H, Austin, Texas 78749 Departments of Clinical Sciences B A H, X L, I L and Radiology Q Y, K H, T Y, A W J, D F P, I P, R E L, University of Texas Southwestern Medical Center, Dallas, Texas 75390 Philips Medical Systems I D, Cleveland, Ohio 44143 and Advanced Imaging Research Center T Y, I P, R E L, University of Texas Southwestern Medical Center, Dallas, Texas 75390
    J Clin Endocrinol Metab 101:1798-806. 2016
    ..Adding liraglutide to high-dose insulin regimens in people with long-standing type 2 diabetes improves insulin secretion, decreases liver and subcutaneous fat but does not alter glucagon secretion. ..
  4. pmc β-cell function preservation after 3.5 years of intensive diabetes therapy
    Lindsay B Harrison
    Department of Internal Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Texas Southwestern Medical Center, Dallas, TX, USA
    Diabetes Care 35:1406-12. 2012
    ..To assess β-cell function preservation after 3.5 years of intensive therapy with insulin plus metformin (INS group) versus triple oral therapy (TOT group) with metformin, glyburide, and pioglitazone...